We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
–
AUM
$157M
AUM Growth
-$22.8M
Cap. Flow
-$11.8M
Cap. Flow %
-7.51%
Top 10 Hldgs %
28.08%
Holding
185
New
10
Increased
91
Reduced
50
Closed
16

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.15M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$1.07M
3
MOH icon
Molina Healthcare
MOH
+$983K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$888K
5
LNG icon
Cheniere Energy
LNG
+$796K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.1M
2
UTHR icon
United Therapeutics
UTHR
+$1.57M
3
MSFT icon
Microsoft
MSFT
+$1.46M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.41M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$971K

Sector Composition

Rank Sector Weight
1 Technology 16.56%
2 Healthcare 15.78%
3 Financials 8.85%
4 Consumer Staples 7.56%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYY icon
101
Sysco
SYY
$40.3B
$449K 0.29%
6,109
+12
+0.2% +$999
T icon
102
AT&T
T
$168B
$444K 0.28%
29,994
-1,397
-4% -$25.4K
INTC icon
103
Intel
INTC
$493B
$443K 0.28%
17,694
+45
+0.3% +$1.53K
NHI icon
104
National Health Investors
NHI
$3.44B
$418K 0.27%
8,110
+227
+3% +$14.3K
ENPH icon
105
Enphase Energy
ENPH
$5.59B
$417K 0.27%
+1,631
New +$440K
BUD icon
106
AB InBev
BUD
$159B
$416K 0.26%
9,256
– –
HDV
107
iShares Core High Dividend ETF
HDV
$15B
$413K 0.26%
21,960
+45
+0.2% +$909
PAYX icon
108
Paychex
PAYX
$43.1B
$412K 0.26%
3,800
+4
+0.1% +$496
AOR icon
109
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.73B
$401K 0.26%
8,990
-4,365
-33% -$211K
CVX icon
110
Chevron
CVX
$386B
$395K 0.25%
2,510
-899
-26% -$137K
FSTA icon
111
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$394K 0.25%
9,708
+15
+0.2% +$661
PSX icon
112
Phillips 66
PSX
$89.5B
$394K 0.25%
4,357
+27
+0.6% +$2.3K
DEO icon
113
Diageo
DEO
$52.8B
$393K 0.25%
2,398
– –
DOW icon
114
Dow Inc
DOW
$22.6B
$375K 0.24%
8,526
+1,006
+13% +$51K
HON icon
115
Honeywell
HON
$72.9B
$374K 0.24%
2,284
+8
+0.4% +$1.39K
TT icon
116
Trane Technologies
TT
$106B
$369K 0.23%
2,505
+2
+0.1% +$299
TMUS icon
117
T-Mobile US
TMUS
$192B
$361K 0.23%
2,655
– –
FDX icon
118
FedEx
FDX
$76.3B
$360K 0.23%
2,366
+45
+2% +$9.5K
ARCC icon
119
Ares Capital
ARCC
$14.3B
$355K 0.23%
20,519
+620
+3% +$12K
SPLV icon
120
Invesco S&P 500 Low Volatility ETF
SPLV
$7.17B
$350K 0.22%
6,075
-14
-0.2% -$885
WBA
121
DELISTED
Walgreens Boots Alliance
WBA
$347K 0.22%
10,633
-432
-4% -$16K
RIVN icon
122
Rivian
RIVN
$23.7B
$342K 0.22%
10,570
-280
-3% -$9.54K
PSEC icon
123
Prospect Capital
PSEC
$1.14B
$341K 0.22%
52,992
+991
+2% +$7.4K
QQQ icon
124
Invesco QQQ Trust
QQQ
$478B
$340K 0.22%
1,293
-304
-19% -$91.7K
VPU
125
Vanguard Utilities ETF
VPU
$8.44B
$340K 0.22%
2,453
– –
3 4
5
6 7

Similar funds

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
VIS
Vega Investment Solutions Paris, France $418M AUM
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return

Roman Butler Fullerton & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Roman Butler Fullerton & Co held 185 positions worth $157M, down 13% from $180M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co withdrew a net $11.8M in Q3 2022, closing 16 positions and reducing 50 holdings. Its most notable exit was United Therapeutics, an estimated $1.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Roman Butler Fullerton & Co opened a new position in Regeneron Pharmaceuticals worth $1.35M.

  • Roman Butler Fullerton & Co's largest Q3 2022 buy was Regeneron Pharmaceuticals: 1,826 shares worth $1.35M.
  • Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $888K increase.
  • Roman Butler Fullerton & Co's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $2.1M.
  • Roman Butler Fullerton & Co fully exited United Therapeutics in Q3 2022, selling an estimated $1.57M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $157M portfolio in Q3 2022.
  • Roman Butler Fullerton & Co opened 10 new positions and closed 16 in Q3 2022.
  • Roman Butler Fullerton & Co's portfolio value fell 13% quarter-over-quarter to $157M.

Based on Roman Butler Fullerton & Co's 13F filing for Q3 2022, filed 17 Oct 2022.